Skip to content

Opening book details…

Can I read Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial on EtoBox?

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial by Atul Deodhar; Philip Mease; Proton Rahman; Victoria Navarro-Compán; Helena Marzo-Ortega; Theresa Hunter; David Sandoval; Andris Kronbergs; Luis Leon; Mingyang Shan; Ann Leung; Kurt De Vlam; Vibeke Strand is a Medicine article available to read on EtoBox.

What is Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial about?

## Introduction Ixekizumab, an interleukin-17A antibody, has shown efficacy in non-radiographic axial spondyloarthritis (nr-axSpA). The objectives of this analysis were (a) to measure improvement in ixekizumab-treated patients in Assessment of Spondyloarthritis International Society (ASAS) response domains and other patient-reported outcomes (PROs) and (b) to determine how ASAS responses were associated with changes in patient global disease activity (PtGA), spinal pain, function, stiffness, fatigue, and spinal pain at night. ## Methods COAST-X was a phase 3, 52-week multicenter, randomized, controlled trial investigating the efficacy and safety of 80-mg ixekizumab every 2 weeks (Q2W) and every 4 weeks (Q4W) in patients with active nr-axSpA. Changes from baseline in PROs were analyzed via mixed-effects models for repeated measures. Association analyses for ASAS responses used analysis of covariance with Scheffé’s method. ## Results Patients treated with ixekizumab Q2W and Q4W reported significantly greater improvements in PtGA, spinal pain, function, and stiffness at week 1, when these measures were first assessed, compared with placebo (__p__ < 0.05). ASAS40 responders, in compari

Who reads Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Atul Deodhar; Philip Mease; Proton Rahman; Victoria Navarro-Compán; Helena Marzo-Ortega; Theresa Hunter; David Sandoval; Andris Kronbergs; Luis Leon; Mingyang Shan; Ann Leung; Kurt De Vlam; Vibeke Strand
Publisher
Springer-Verlag; [London]: Springer Healthcare, 2014; Springer Science and Business Media LLC (ISSN 2198-6576)
Published
2020
Language
EN
Field
Medicine (Health Sciences)

More by Atul Deodhar; Philip Mease; Proton Rahman; Victoria Navarro-Compán; Helena Marzo-Ortega; Theresa Hunter; David Sandoval; Andris Kronbergs; Luis Leon; Mingyang Shan; Ann Leung; Kurt De Vlam; Vibeke Strand

Browse all works by Atul Deodhar; Philip Mease; Proton Rahman; Victoria Navarro-Compán; Helena Marzo-Ortega; Theresa Hunter; David Sandoval; Andris Kronbergs; Luis Leon; Mingyang Shan; Ann Leung; Kurt De Vlam; Vibeke Strand